EyePoint Pharmaceuticals ...

NASDAQ: EYPT · Real-Time Price · USD
10.71
-0.14 (-1.29%)
At close: Aug 15, 2025, 3:06 PM

EyePoint Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
43.27M 46.02M 41.4M 36.94M
Cost of Revenue
3.71M 4.63M 8.33M 8.18M
Gross Profit
39.56M 41.39M 33.08M 28.76M
Operating Income
-145.85M -75.07M -78.94M -55.28M
Interest Income
15.09M 6.95M 2.13M 292K
Pretax Income
-130.78M -70.71M -102.25M -58.42M
Net Income
-130.87M -70.8M -124.51M -63.91M
Selling & General & Admin
52.49M 51.79M 60.32M 53.08M
Research & Development
132.93M 64.66M 49.64M 28.5M
Other Expenses
n/a n/a 2.05M 2.46M
Operating Expenses
185.41M 115.05M 112.02M 84.04M
Interest Expense
14K 1.25M 3.19M 5.5M
Selling & Marketing Expenses
131K 11.69M 25.51M 27.5M
Cost & Expenses
189.13M 121.08M 120.34M 92.22M
Income Tax Expense
90K 83K 22.26M 5.5M
Shares Outstanding (Basic)
56.3M 38.9M 37.32M 28.76M
Shares Outstanding (Diluted)
56.3M 38.9M 37.32M 28.76M
EPS (Basic)
-2.32 -1.82 -3.34 -2.22
EPS (Diluted)
-2.32 -1.82 -3.34 -2.22
EBITDA
-129.23M -69M -96.62M -50.15M
EBIT
-130.77M -69.47M -99.06M -52.92M
Depreciation & Amortization
1.54M 464K 2.45M 2.77M